Preventive effects of Brassicaceae family for colon cancer prevention: A focus on in vitro studies
Metadata
Show full item recordAuthor
Peña Contreras, María Mercedes; Guzmán, Ana; Martínez Martínez, Rosario; Mesas Hernández, Cristina; Prados Salazar, José Carlos; Porres Foulquie, Jesús María; Melguizo Alonso, ConsolaciónEditorial
Elsevier
Materia
Brassicaceae family Colon cancer Antitumor activity Bioactive compounds In vitro assay
Date
2022-05-25Referencia bibliográfica
Mercedes Peña... [et al.]. Preventive effects of Brassicaceae family for colon cancer prevention: A focus on in vitro studies, Biomedicine & Pharmacotherapy, Volume 151, 2022, 113145, ISSN 0753-3322, [https://doi.org/10.1016/j.biopha.2022.113145]
Sponsorship
Spanish Government RTC2019-006870-1; Junta de Andalucia P18-TP-1420; Granada University; CELLBITEC S.L.; FPU2019 grant from the Ministerio de Universidades (Spain) FPU19/06170; Spanish Government DIN2018009995B04847216; Andalusian Government AGR145 CTS-107Abstract
The emergence of adverse effects and resistance to colorectal cancer (CRC) current therapies calls for the
development of new strategies aimed at both preventing and treating. In this context, functional extracts from
Brassicaceae family contains abundant bioactive compounds directly related to a positive effect on human health
including cancer. The main objective of this systematic review is to compile all recent studies that analyzed the in
vitro antiproliferative activity of functional extracts or isolated molecules from the Brassicaceae family against
CRC. A total of 711 articles published between January 2011 and May 2021 were identified. Of them, 68 met our
inclusion criteria. Different standardized protocols using variable parts of plants of the Brassicaceae family
resulted in diverse bioactive extracts and/or compounds. Most of them were related to isothiocyanates, which
showed significant antitumor activity against CRC. These in vitro studies provide an excellent guide to direct
research on the applications of plants of the Brassicaceae family to the prevention of this type of tumor. The
extracts and molecules with demonstrated activity against CRC should be tested in vivo and in clinical trials to
determine their usefulness in the prevention of this cancer to reduce its global incidence.